Loading…
Hosted by Terri Vidals · 🇺🇸 US · EN · 165 episodes
Established thought leaders with verified media credentials.
For everyone in the healthcare industry looking to reduce substance abuse and drug diversion. The host, Terri Vidals, is a pharmacist with over 30 years of experience; fifteen of those years in medication safety and drug diversion prevention and monitoring. Listen to an interview each week with a healthcare professional involved in diversion detection. Learn about how to leverage artificial intelligence to detect diversion and get exposure to products or services designed to facilitate diversion detection.
Terri Vidals hosts Drug Diversion Insights with Terri Vidals, a health show with 165 episodes published.
Every diversion investigation begins with data—but the quality of your conclusions depends on the objectivity of your audit. In this Quick Take on Diversion Insights , Terri explores one of the most overlooked challenges
What exactly counts as a "significant loss" of controlled substances? It's one of the most common questions in diversion prevention—and one the DEA intentionally leaves unanswered. That ambiguity can make reporting decis
Drug diversion is a global challenge, but not every country approaches it the same way. In this episode of Drug Diversion Insights , Terri welcomes Mark Jackson , whose work in the United Kingdom is roughly equivalent to
Think you need diversion analytics software to identify diversion risk? Think again. In this Quick Take on Diversion Insights , Terri shares a practical, structured approach to diversion monitoring using reports that mos
How can healthcare organizations better support professionals in recovery—and help them seek assistance before substance use disorder impacts their lives, patients, or careers? In this episode of Drug Diversion Insights
Most diversion analytics platforms are built to monitor controlled substance activity. That's where the regulatory focus is, and that's where most dashboards direct attention. But what if an important diversion risk is h
What if the most effective way to fight the addiction crisis starts long before overdose—at the point of the very first prescription? In this episode of Drug Diversion Insights, Terri sits down with Dr. Paul Lynch, anest
What happens when the person diverting drugs in the OR is someone you trust completely—a colleague, a mentor, a friend standing right beside you at the table? In this episode of Drug Diversion Insights, Terri sits down w
The most sophisticated diversion monitoring tools are only as effective as the culture surrounding them. In this Diversion Insights Quick Take, we explore why staff engagement is one of the most important—and most overlo
What happens when addiction is hidden within a high-trust profession? In this episode of Drug Diversion Insights, pharmacist Steve Leuck shares his personal journey through cocaine and opioid addiction while continuing t
You don’t need expensive surveillance software to start identifying diversion risk. In this Diversion Insights Quick Take, we explore how manual auditing using ADM data can be a practical and effective way to detect earl
Are anesthesia discrepancies just documentation issues—or signals of deeper risk? In this episode of Drug Diversion Insights, Terri sits down with Dr. Jenny Dolan, Division Chief of Pediatric Anesthesia and Director of T
Controlled substance waste is one of the most vulnerable points in the medication-use process—and one of the most common gaps in diversion prevention programs. In this Diversion Insights Quick Take, we explore why delaye
In this episode of Drug Diversion Insights, Terri sits down with Dr. Don Teater, a leading expert in pain management and addiction medicine, for a deeper exploration of buprenorphine—through both a clinical and neuroscie
Controlled substance drips and PCA infusions present unique challenges when it comes to maintaining a clear chain of custody. One of the most overlooked vulnerabilities occurs during handoffs—when responsibility for thes
Few medications in addiction treatment generate as much debate as buprenorphine. After receiving significant listener feedback describing difficult experiences with this medication—particularly around discontinuation—Ter
When poor medication administration practices become routine, they create noise—noise that makes it nearly impossible to identify true drug diversion. Shortcuts, workarounds, and inconsistent documentation don’t just wea
Drug diversion investigations in healthcare are among the most sensitive interviews an investigator can conduct. When handled poorly, these interviews can fail to uncover the truth—and permanently damage an innocent prof
Should a nurse or a pharmacist lead a drug diversion program? It’s a question that comes up often—and one that misses the bigger point. In this episode of Rxpert Solutions, we explore what truly matters in diversion prog
Propofol may not be federally classified as a controlled substance—but that doesn’t mean it’s low risk. In this Diversion Insights Quick Take from Rxpert Solutions, we explore why propofol remains one of the most challen
Dr. Paul Lynch
double board-certified anesthesiologist and pain management specialist · Elm Tree Garden Contractors
1 appearance on this show
Carol Davis
Chair Of The Illinois Conservative Union · Illinois Conservative Union
1 appearance on this show
Dave Thompson
Author of Brainstorm: Neurodivergent Talent and the Future of Work · Vanderbilt's Frist Center for Autism and Innovation
1 appearance on this show
Dr. Mary Nelson
Dr. · The Mary Nelson Youth Center
1 appearance on this show
Detected from recent episode content. Sponsor presence is a real signal of listener purchasing power and show monetisation.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Drug Diversion Insights with Terri Vidals has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.
Drug Diversion Insights with Terri Vidals is hosted by Terri Vidals. The show is categorised under health (fitness) and has published 165 episodes.
Drug Diversion Insights with Terri Vidals has published 165 episodes.
Drug Diversion Insights with Terri Vidals regularly covers health, fitness, mental. It sits in the health category, with a fitness focus.
Drug Diversion Insights with Terri Vidals is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Drug Diversion Insights with Terri Vidals hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Drug Diversion Insights with Terri Vidals average 25 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Drug Diversion Insights with Terri Vidals's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 11 days ago.